Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease

NCT00184652 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease
End-Stage Renal Disease

Interventions

DRUG: somatropin

Sponsor

Novo Nordisk A/S